Analystreport

Moleculin Biotech, Inc. (NASDAQ: MBRX) had its price target lowered by analysts at Roth Capital from $29.00 to $16.00.

Moleculin Biotech, Inc.  (MBRX) 
Last moleculin biotech, inc. earnings: 8/16 05:35 pm Check Earnings Report
US:NASDAQ Investor Relations: moleculin.com/investors